Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

Can New Antimalarials Be a Gamechanger in Endemic Countries?

JUN 16, 2017 | CONTAGION® EDITORIAL STAFF


Jeremy Burrows, DPhil, MA, Vice President, Head of Discovery, Medicines for Malaria Venture, Switzerland, explains how new antimalarials could change the game for countries where malaria is endemic.
 
Interview Transcript (slightly modified for readability)

“In the countries where malaria is endemic, these new treatment options are still incredibly important. First, because they will provide the treatment options of the future when the existing drugs fail because of resistance. Secondly, we have this ambition for elimination, eradication, and these new drugs, which are coming through the pipeline we hope will deliver the tools that will actually enable us to do that.”
 
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.